SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-008603
Filing Date
2021-04-13
Accepted
2021-04-13 08:50:18
Documents
11
Period of Report
2021-04-13
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 39144
2 ex1.htm EX-1 6171
3 ex2.htm EX-2 1000
4 ex1_001.jpg GRAPHIC 118621
5 ex1_002.jpg GRAPHIC 116837
6 ex1_003.jpg GRAPHIC 211298
7 ex1_004.jpg GRAPHIC 158855
8 ex1_005.jpg GRAPHIC 180725
9 ex1_006.jpg GRAPHIC 182762
10 ex1_007.jpg GRAPHIC 134057
11 ex2_001.jpg GRAPHIC 153704
  Complete submission text file 0001493152-21-008603.txt   1779024
Mailing Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024 201-464-2677
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36602 | Film No.: 21822082
SIC: 2834 Pharmaceutical Preparations